22157.jpg
Global Community Oncology Services Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
10 janv. 2022 04h23 HE | Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Community Oncology Services Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Picture1.jpg
Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
05 janv. 2022 08h01 HE | Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and virology,...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Present at H.C. Wainwright Bioconnect Virtual Conference
04 janv. 2022 07h00 HE | FibroGen, Inc.
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the H.C....
Sunshine Biopharma Logo
Sunshine Biopharma Announces $1,361,000 in Debt Reduction
22 déc. 2021 08h52 HE | Sunshine Biopharma Inc.
MONTREAL, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year
13 déc. 2021 07h31 HE | HCW Biologics, Inc
MIRAMAR, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel...
Black-Enochian-Primary-Logo.jpg
Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors
03 déc. 2021 07h00 HE | Enochian BioSciences, Inc.
LOS ANGELES, Dec. 03, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
EDRN's Pancreatic Cancer Detection Group Teams With Rhino Health to Leverage Federated Learning and Accelerate Medical Research
23 nov. 2021 09h00 HE | Rhino HealthTech, Inc.
BOSTON, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Rhino Health today announced a pilot project with the pancreatic cancer working group of the National Cancer Institute's Early Detection Research Network...
Cend_ID_Color.jpg
Cend Therapeutics Announces First Patient Dosing in Clinical Trial of CEND-1 for the Treatment of Selected Gastrointestinal Cancers
16 nov. 2021 06h00 HE | Cend Therapeutics Inc.
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Patient dosing has begun in a Phase 1b/2a clinical trial to evaluate the safety, tolerability and pharmacologic activity of CEND-1 in pancreatic,...
HCW Logo_Full_Color_600x_JPEG (2).jpg
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
12 nov. 2021 07h00 HE | HCW Biologics, Inc
MIRAMAR, Fla., Nov. 12, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), an innovative biopharmaceutical company focused on discovering and developing...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Present at Upcoming Investor Conferences
02 nov. 2021 07h00 HE | FibroGen, Inc.
SAN FRANCISCO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the following...